Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): Pre- and post-rituximab

Annals of Hematology

Volumn 90, Issue 7, 2011, Pages 809-818

  Tai, W M ^a   Chung, J ^a   Tang, P L ^a   Koo, Y X ^a   Hou, X ^b   Tay, K W ^a   Quek, R ^a   Tao, M ^a   Lim, S T ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b Division of Clinical Trials and Epidemiology Science   (Singapore)

Author keywords

CNS relapse; DLBCL; Incidence; Intrathecal prophylaxis; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER REGRESSION; CANCER RELAPSE; CENTRAL NERVOUS SYSTEM LYMPHOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; RECURRENCE; VINCRISTINE;

EID: 79960283082     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1150-7     Document Type: Article

References (18)

1. D Villa JM Connors TN Shenkier RD Gascoyne LH Sehn KJ Savage 2010 Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy Ann Oncol 21 1046 1052 19861575 10.1093/annonc/mdp432 1:STN:280:DC%2BC3c3ptFyktg%3D%3D
2. V Boehme S Zeynalova M Kloess M Loeffler U Kaiser M Pfreundschuh N Schmitz 2007 Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocol of German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) Ann Oncol 18 149 157 17018708 10.1093/annonc/mdl327 1:STN:280:DC%2BD2s%2FisVWnsw%3D%3D (Pubitemid 46152515)
3. V Boehme N Schmitz S Zeynalova M Loeffler M Pfreundschuh 2009 CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) Blood 113 3896 3901 19144985 10.1182/blood-2008-10-182253 1:CAS:528:DC%2BD1MXlsVWrsL4%3D
4. T Shimazu K Notohara Y Ueda 2009 Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single centre experience Int J Hematol 89 577 583 19353238 10.1007/s12185-009-0289-2 1:CAS:528:DC%2BD1MXms1KksrY%3D
5. ND Doolittle LE Abrey E Zucca TN Shenkier S Tali JE Bromberg EA Neuwelt C Soussain K Johnke P Johnston G Illerhaus D Schiff T Batchelor S Montoto K Df E Zucca 2008 Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report Blood 111 1085 1093 17962515 10.1182/blood-2007-07- 101402 1:CAS:528:DC%2BD1cXhvFejsbo%3D (Pubitemid 351213386)
6. K Van Besien CS Ha S Murphy P McLaughlin A Rodriguez K Amin A Forman J Romaguera F Hagemeister A Younes C Bachier A Sarris KS Sobocinski JD Cox F Cabanillas 1998 Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma Blood 1998 1178 1184 (Pubitemid 28086870)
7. SH Bernstein JM Unger M Leblanc J Friedberg TP Miller RI Fisher 2009 Natural history of CNS relapse in patients with aggressive non-Hodgkin lymphoma: a 20-year follow up analysis of SWOG 8516-The Southwest Oncology Group J Clin Oncol 27 114 119 19047289 10.1200/JCO.2008.16.8021
8. HT Arkenau G Chong D Cunningham D Watkins R Agarwal B Sirohi M Trumper A Norman A Wotherspoon A Horwich 2007 The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma Ann Oncol 18 541 545 17164228 10.1093/annonc/mdl434 (Pubitemid 46359636)
9. B Coiffier E Lepage J Briere R Herbrecht H Tilly R Bouabdallah P Morel E Van Den Neste G Salles P Gaulard F Reyes P Lederlin C Gisselbrecht 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma N Engl J Med 346 235 242 11807147 10.1056/NEJMoa011795 1:CAS:528:DC%2BD38XmslGgsw%3D%3D (Pubitemid 34438862)
10. P Feugier A Van Hoof C Sebban, et al. 2005 Long term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de I'Adulte J Clin Oncol 23 4117 4126 15867204 10.1200/JCO.2005.09.131 1:CAS:528:DC%2BD2MXmt1elsr0%3D (Pubitemid 46211317)
11. M Pfreundshcuh L Trumper A Osterborg, et al. 2006 CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 10.1016/S1470-2045(06)70664-7
12. TM Haberman EA Weller VA Morrison, et al. 2006 Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 24 3121 3127 10.1200/JCO.2005.05.1003 (Pubitemid 46638950)
13. M Pfreundshcuh Z Schubert M Ziepert, et al. 2008 Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomized controlled trial (RICOVER-60) Lancet Oncol 9 105 116 10.1016/S1470-2045(08)70002-0
14. W Yamamoto Y Ishigatsubo, et al. 2010 Central nervous system involvement in diffuse large B-cell lymphoma Eur J Hematol 85 6 10 1:CAS:528: DC%2BC3cXpslOksr8%3D
15. U Hegde A Filie RF Little JE Janik N Grant SM Steinberg K Dunleavy Es Jaffe A Abati M Stetler-Stevenson WH Wilson 2005 High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for CNS involvement: the role of flow cytometry versus cytology Blood 105 496 502 15358629 10.1182/blood-2004-05-1982 1:CAS:528:DC%2BD2MXltlGisw%3D%3D (Pubitemid 40070727)
16. H Tilly E Lepage B Coiffier M Blanc R Herbrecht A Bosly M Attal G Fillet C Guettier TJ Molina C Gisselbrecht F Reyes 2003 Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non Hodgkin lymphoma Blood 102 4284 4289 12920037 10.1182/blood-2003-02-0542 1:CAS:528:DC%2BD3sXpslGrsrg%3D (Pubitemid 37494085)
17. N Gokbuget D Hoelzer 2002 Recent approaches in acute lymphoblastic leukemia in adults Rev Clin Exp Hematol 6 114 140 12196212 10.1046/j.1468-0734. 2002.00068.x
18. N Gokbuget D Hoelzer 1998 Meningeosis leukaemia in adult acute lymphoblastic leukaemia J Neuro Oncol 38 167 180 10.1023/A:1005963732481 1:STN:280:DyaK1czlvFGmtQ%3D%3D (Pubitemid 28306204)